Literature DB >> 9389684

Adenoviral E1A-associated protein p300 is involved in acute myeloid leukemia with t(11;22)(q23;q13).

K Ida1, I Kitabayashi, T Taki, M Taniwaki, K Noro, M Yamamoto, M Ohki, Y Hayashi.   

Abstract

p300, which was originally cloned as a nuclear binding target of the adenovirus E1A oncoprotein, forms a family with cyclic-AMP response element binding protein (CREB)-binding protein (CBP). p300/CBP are considered to be transcriptional coactivators that connect the basal transcriptional machinery to various DNA-binding transcriptional factors. p300/CBP are implicated in both cell differentiation and regulation of cell-cycle. We identify here that the p300 gene is fused to the MLL gene and that in-frame MLL-p300 fusion protein is generated in acute myeloid leukemia (AML) with t(11; 22)(q23; q13). These findings suggest that the basis for the leukemogenesis of t(11; 22)-AML is the inability of p300 to regulate cell-cycle and cell differentiation after fusion with MLL.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9389684

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  52 in total

1.  MLL and CREB bind cooperatively to the nuclear coactivator CREB-binding protein.

Authors:  P Ernst; J Wang; M Huang; R H Goodman; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.

Authors:  R W Johnstone; M Gerber; T Landewe; A Tollefson; W S Wold; A Shilatifard
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

3.  A function of CBP as a transcriptional co-activator during Dpp signalling.

Authors:  L Waltzer; M Bienz
Journal:  EMBO J       Date:  1999-03-15       Impact factor: 11.598

4.  Activation of AML1-mediated transcription by MOZ and inhibition by the MOZ-CBP fusion protein.

Authors:  I Kitabayashi; Y Aikawa; L A Nguyen; A Yokoyama; M Ohki
Journal:  EMBO J       Date:  2001-12-17       Impact factor: 11.598

Review 5.  Insight into the tumor suppressor function of CBP through the viral oncoprotein tax.

Authors:  K Van Orden; J K Nyborg
Journal:  Gene Expr       Date:  2000

6.  CBP/p300 interact with and function as transcriptional coactivators of BRCA1.

Authors:  G M Pao; R Janknecht; H Ruffner; T Hunter; I M Verma
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

7.  MLL-AFX requires the transcriptional effector domains of AFX to transform myeloid progenitors and transdominantly interfere with forkhead protein function.

Authors:  Chi Wai So; Michael L Cleary
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

8.  Trisomy 22 as the sole karyotypic abnormality in myelodysplastic syndrome.

Authors:  Tohru Takahashi; Sayaka Harada; Mariko Oki; Mitsuru Yoshimoto; Masayuki Tsujisaki
Journal:  Int J Hematol       Date:  2005-04       Impact factor: 2.490

Review 9.  Roles of a trithorax group gene, MLL, in hematopoiesis.

Authors:  Ryoichi Ono; Tetsuya Nosaka; Yasuhide Hayashi
Journal:  Int J Hematol       Date:  2005-05       Impact factor: 2.490

10.  PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-mediated degradation.

Authors:  Yutaka Shima; Takito Shima; Tomoki Chiba; Tatsuro Irimura; Pier Paolo Pandolfi; Issay Kitabayashi
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.